Evolent Health ROA 2014-2026 | EVH
Current and historical return on assets (ROA) values for Evolent Health (EVH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Evolent Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-06-30 | $-0.51B | $2.05B | -24.92% |
| 2026-03-31 | $-0.53B | $2.17B | -24.57% |
| 2025-12-31 | $-0.58B | $2.37B | -24.46% |
| 2025-09-30 | $-0.18B | $2.53B | -7.16% |
| 2025-06-30 | $-0.19B | $2.54B | -7.28% |
| 2025-03-31 | $-0.14B | $2.54B | -5.50% |
| 2024-12-31 | $-0.09B | $2.54B | -3.66% |
| 2024-09-30 | $-0.10B | $2.58B | -4.00% |
| 2024-06-30 | $-0.11B | $2.62B | -4.01% |
| 2024-03-31 | $-0.14B | $2.66B | -5.26% |
| 2023-12-31 | $-0.14B | $2.65B | -5.33% |
| 2023-09-30 | $-0.11B | $2.43B | -4.57% |
| 2023-06-30 | $-0.08B | $2.20B | -3.45% |
| 2023-03-31 | $-0.04B | $1.87B | -2.14% |
| 2022-12-31 | $-0.02B | $1.56B | -1.22% |
| 2022-09-30 | $-0.01B | $1.46B | -0.96% |
| 2022-06-30 | $-0.03B | $1.33B | -2.18% |
| 2022-03-31 | $-0.03B | $1.33B | -2.49% |
| 2021-12-31 | $-0.04B | $1.32B | -2.88% |
| 2021-09-30 | $-0.05B | $1.31B | -3.60% |
| 2021-06-30 | $-0.07B | $1.34B | -5.30% |
| 2021-03-31 | $-0.27B | $1.34B | -19.93% |
| 2020-12-31 | $-0.34B | $1.37B | -24.43% |
| 2020-09-30 | $-0.52B | $1.40B | -36.93% |
| 2020-06-30 | $-0.51B | $1.48B | -34.18% |
| 2020-03-31 | $-0.34B | $1.58B | -21.22% |
| 2019-12-31 | $-0.30B | $1.62B | -18.67% |
| 2019-09-30 | $-0.12B | $1.68B | -7.27% |
| 2019-06-30 | $-0.11B | $1.58B | -6.83% |
| 2019-03-31 | $-0.09B | $1.50B | -5.74% |
| 2018-12-31 | $-0.05B | $1.42B | -3.74% |
| 2018-09-30 | $-0.05B | $1.32B | -3.72% |
| 2018-06-30 | $-0.05B | $1.31B | -3.82% |
| 2018-03-31 | $-0.06B | $1.26B | -4.51% |
| 2017-12-31 | $-0.06B | $1.23B | -4.98% |
| 2017-09-30 | $-0.07B | $1.20B | -5.43% |
| 2017-06-30 | $-0.06B | $1.09B | -5.80% |
| 2017-03-31 | $-0.05B | $1.02B | -5.32% |
| 2016-12-31 | $-0.16B | $0.94B | -16.91% |
| 2016-09-30 | $-0.15B | $0.89B | -16.44% |
| 2016-06-30 | $-0.15B | $0.95B | -15.66% |
| 2016-03-31 | $0.22B | $0.99B | 22.18% |
| 2015-12-31 | $0.33B | $0.80B | 41.41% |
| 2015-09-30 | $0.33B | $0.55B | 59.76% |
| 2015-06-30 | $0.34B | $0.29B | 117.61% |
| 2015-03-31 | $-0.03B | $0.03B | -95.58% |
| 2014-12-31 | $-0.03B | $0.01B | -281.08% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.464B | $1.876B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |